PRAC holds its first public hearing for review of the safety of using valproate-containing medicines in women and girls who are pregnant or of childbearing age. There is a
The FDA in the USA has announced a “breakthrough therapy” for post traumatic stress disorder (PTSD). The regulator has determined the drug MDMA, commonly known as ecstasy, can
The MHRA issued a warning in August about potentially unreliable HIV testing kits, manufactured by Qingdao Hightop Biotech Co Ltd. The regulator seized 114 of the Hightop
Danish pharmaceutical giant Novo Nordisk has recalled batches of faulty insulin pens in the UK, the MHRA has announced. Certain batches of the NovoPen Echo and NovoPen 5 are
A new agreement has been reached between the US and EU regulators for regulatory inspections. The FDA, the EU Commission and EMA have signed a confidentiality commitment which
Britain’s second largest drugmaker AstraZeneca has announced it will expand its existing site in Macclesfield in Cheshire. This will give a much needed boost to the UK’s £60bn
The drive to maintain well being has just taken on a whole new dimension. It seems we are now relying more and more on biological solutions to look after our health and the
Concerns have been raised for the safety of the popular anti- diarrhoea medicine Imodium (active ingredient loperamide) following the death of a young father from an overdose
Campaign group the Alliance for Natural Health International (ANHI), has reported girls who have opted out of taking the human papilloma virus (HPV) vaccination are being
In October last year, we ran an article about the practice of fake dental devices being sold online. The sale of fake dental equipment online continues to be a problem for the